Yan Leyfman, MD
yleyfman.bsky.social
Physician | Executive Director & Host MedNews Week | Medical Correspondent | Conference Director | Journal Editor | Educator | Research #Oncology #COVID19 #Immunotherapy #celltherapy #tcellrx #CART #bmtsm #MedSKY #ONCSKY | About Me: http://nyti.ms/2VG3gUK
👤 Joined on 12 November 2024
1120
Followers
653
Following
656
Total Posts
📜 Kullanıcı Geçmişi
- 12 Kas 2024, 01:20
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@yleyfman.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Episode 5 of The Translational Edge With Yan Leyfman on Exercise in Cancer Care - Jeremy Bellaiche @yleyfman.bsky.social oncodaily.com/voices/yan-l... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Show PostGene Editing Rapidly Redefines What is Possible in Sickle Cell Disease - Yan Leyfman @yleyfman.bsky.social oncodaily.com/voices/yan-l... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Show PostEpcoritamab Integrated Upfront into Salvage Therapy in R/R DLBCL - Yan Leyfman @yleyfman.bsky.social oncodaily.com/voices/yan-l... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Show PostTeaching Cancer-Fighting Cells to Recharge - Yan Leyfman @yleyfman.bsky.social oncodaily.com/voices/yan-l... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Show Post
Busy couple of weeks. Participated in meetings at Georgetown Law (affordability of cancer drugs), John’s Hopkins Carey School of Business (innovation in healthcare), and Clinton Foundation (breast cancer research funding).
Show Post